Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Interventional Cardiology
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Interventional Cardiology
    Pretreatment With Enoxaparin, Fondaparinux Improves Survival in Patients With Acute MI Awaiting PCI: Presented at AHA - (DGDispatch)
    Statins Can Reduce Risk of Major Cardiovascular Events in Healthy Women: Presented at AHA - (DGDispatch)
    Long-Term Outcome Associated with Early Repolarization on Electrocardiography - (N Engl J Med)
    Multivessel PCI Does Not Improve 1-Year Survival in Patients With Multivessel Disease: Presented at AHA - (DGDispatch)
    Intravenous Platelet Blockade with Cangrelor during PCI - (N Engl J Med)

    News archive

     Recent webcasts/CME - Interventional Cardiology
      PreAnesthetic Assessment of the Patient With Cardiomyopathy
      Pulmonary Hypertension: Advances in Pulmonary Hypertension
      New Clinical Evidence for Home Monitoring: Towards Safe, Need-based Patient Follow-up and Beyond
      Simplification of AF: Integration of 3D Imaging, Mapping, and Ablation
      Emerging Trends in the Management of Arrhythmias and Pump Failure in Patients with Advanced HF

      Webcasts/CME archive

       Recent cases - Interventional Cardiology
        Coronary-pulmonary Artery Fistula with Anomalous Vessels Arising from the Right Coronary Sinus Detected by 64-MDCT
        Sudden Shortness of Breath and Bradycardia Leading to Dual-Chamber Pacemaker Placement in a 78-Year-Old Man
        Myocardial Ischemia with Left Ventricular Outflow Obstruction
        Successful Non Contrast Percutaneous Coronary Intervention for Patient with Unstable Angina and Prior Anaphylactic Reaction to Iodinated Contrast Medium
        Quantitative Assessment of Dyssynchrony Using ECG-Gated SPECT Myocardial Perfusion Imaging Prior to and Following Cardiac Resynchronization Therapy

        Cases archive
          




        my personal edition > interventional cardiology > news
        divider

          E-Mail this DGNews to a colleague

        DGNews


        Dangers of Stopping Clopidogrel (Plavix) for Patients With Stents and Certain Other Conditions

        A public health alert from the American College of Cardiology

        BETHESDA, M.D. -- March 17, 2006 -- Recent media reports regarding the results of the CHARISMA Trial may be misinterpreted by patients with coronary stents and other conditions*, causing these patients to inappropriately stop taking the anti-clotting drug clopidogrel (Plavix®). Patients taking Plavix® for any reason should consult with their cardiologist or other health care provider before stopping this medication.

        The CHARISMA Trial was presented at the Annual Scientific Sessions of the American College of Cardiology on Sunday, March 12 in Atlanta and simultaneously published in the New England Journal of Medicine. Although the CHARISMA trial showed no benefit to combining Plavix® and aspirin and for certain patients, this study does not invalidate use of the drug for approved indications, such as stenting. Certain other patients are given Plavix® after hospitalization for heart attack or stroke. Patients with these conditions must discuss the benefits and risks of anti-clotting medication with their health care provider and should not stop Plavix® on their own. Discontinuation of Plavix® in patients with recently-placed stents can cause clot formation within the stent, resulting in serious harm or death.

        * According to the 2006 ACC/AHA/SCAI Guideline Update for Percutaneous Coronary Intervention (PCI), Class I recommendations indicate the use of aspirin and clopidogrel in patients undergoing angioplasty with stent implantation (contraindications include aspirin resistance, allergy or risk of bleeding).


        SOURCE: American College of Cardiology



        E-Mail this DGNews to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send